Piramal Pharma Limited (PPLPHARMA) — Cash Flow Quality Index
Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Quality Index of 36.86x as of December 2023. Operating cash flow of Rs3.73 Billion exceeds net income of Rs101.10 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Piramal Pharma Limited to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Piramal Pharma Limited Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Piramal Pharma Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Piramal Pharma Limited generate cash.
Annual Cash Flow Quality Index for Piramal Pharma Limited (2021–2025)
Year-by-year earnings quality comparison for Piramal Pharma Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.79x | Rs8.92 Billion | Rs911.30 Million | ▼ -82.6% |
| 2024 | 56.37x | Rs10.05 Billion | Rs178.20 Million | ▲ +9546.3% |
| 2022 | 0.58x | Rs2.55 Billion | Rs4.37 Billion | ▲ +487.6% |
| 2021 | 0.10x | Rs347.20 Million | Rs3.49 Billion | — |